Tokai Pharmaceuticals' Grant

Tokai Pharmaceuticals raised a round of funding on April 22, 2009. Investors include Qualifying Therapeutic Discovery Project.

Tokai Pharmaceuticals (NASDAQ:TKAI) is a biopharmaceutical company focused on developing and commercializing therapies for prostate cancer and other hormonally driven diseases. The company's lead drug…

Articles about Tokai Pharmaceuticals' Grant: